Publications by authors named "Ayfa Riaz Bajwa"
Article Synopsis
- - Breast cancer is the second leading cause of cancer-related deaths; antibody-drug conjugates (ADCs) target specific tumor proteins, offering potent treatment with less toxicity compared to traditional chemotherapy.
- - A meta-analysis of 14 clinical trials (N = 5,960) found that ADCs significantly improved progression-free survival (PFS) and overall survival (OS) in patients with HER-2 positive and triple-negative breast cancer compared to chemotherapy.
- - The study highlighted that among ADCs, trastuzumab-deruxtecan (T-der) showed superior effectiveness over trastuzumab-emtansine (T-DM1), with common serious side effects including anemia and fatigue observed in a small percentage of
